Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma

Medical Oncology

Volumn 25, Issue 2, 2008, Pages 201-206

  Yuan, Jeng Nian ^a,b   Chao, Yee ^a,b,c   Lee, Wei Ping ^a,b   Li, Chung Pin ^a,b   Lee, Rheun Chuan ^a,b   Chang, Full Young ^a,b   Yen, Sang Hue ^a,b   Lee, Shou Dong ^a,b   Whang Peng, Jacqueline ^d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Central Clinic Hospital   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

5 fluouracil; Cisplatin; Doxorubicin; Etoposide; Hepatocellular carcinoma; Leucovorin

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; ANTINEOPLASTIC AGENT;

ADULT; AGED; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; HYPERPIGMENTATION; KIDNEY FUNCTION; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; NEPHROTOXICITY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING; ADOLESCENT; FEMALE; LIVER TUMOR; MALE; MIDDLE AGED; MORTALITY;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 48049120897     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-007-9013-3     Document Type: Article

References (29)

1. CH Chen DS. Chen 1992 Hepatocellular carcinoma: 30-year experience in Taiwan J Formos Med Assoc 91 Suppl 3 187 202
2. Bartlett DL, Carr B, Marsh JW. Cancer of the liver. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principle and practice of oncology. 7th ed. Philadelphia: J.B. Lippincott; 2005. p. 986-1009.
3. JM Llovet A Burroughs J. Bruix 2003 Hepatocellular carcinoma Lancet 362 1907 17
4. JS Link JR Bateman WS Paroly WJ Durkin RL. Peters 1977 5-Flourouracil in hepatocellular carcinoma: report of twenty-one cases Cancer 39 1936 9
5. WB Looney MS Macleod HA. Hopkins 1978 Solid tumour models for the assessment of different treatment modalities: VII: single vs fractionated doses of 5-fluorouracil on two solid tumours and their hosts Br J Cancer 37 841 8
6. H Ueno S Okada T Okusaka M Ikeda H. Kuriyama 2002 Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma Cancer Chemother Pharmacol 49 155 60
7. K Keyomarsi RG. Moran 1988 Mechanism of the cytotoxic synergism of fluoropyrimidines and folinic acid in mouse leukemic cells J Biol Chem 263 14402 9
8. M Tetef J Doroshow S Akman P Coluzzi L Leong K Margolin 1995 5-Fluorouracil and high-dose calcium leucovorin for hepatocellular carcinoma: a phase II trial Cancer Invest 13 460 3
9. C Porta M Moroni G Nastasi G. Arcangeli 1995 5-Fluorouracil and d,l-leucovorin calcium are active to treat unresectable hepatocellular carcinoma patients: preliminary results of a phase II study Oncology 52 487 91
10. T Kogure Y Ueno T Iwasaki T. Shimosegawa 2004 The efficacy of the combination therapy of 5-fluorouracil, cisplatin and leucovorin for hepatocellular carcinoma and its predictable factors Cancer Chemother Pharmacol 53 296 304
11. H Tanioka A Tsuji S Morita T Horimi M Takamatsu T Shirasaka 2003 Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma Anticancer Res 23 1891 7
12. E Boucher S Corbinais P Brissot K Boudjema JL. Raoul 2002 Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen) Cancer Chemother Pharmacol 50 305 8
13. WM Melia PJ Johnson R. Williams 1983 Induction of remission in hepatocellular carcinoma. A comparison of VP 16 with adriamycin Cancer 51 206 10
14. DC Ihde RC Kane MH Cohen KR McIntire JD. Minna 1977 Adriamycin therapy in American patients with hepatocellular carcinoma Cancer Treat Rep 61 1385 7
15. K. Okuda 1986 Early recognition of hepatocellular carcinoma Hepatology 6 729 38
16. American Joint Committee on Cancer. Manual for staging of cancer. 6th ed. New York: Springer-Verlag; 2002.
17. The Cancer of the Liver Italian Program (CLIP) investigators 1998 A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators Hepatology 28 751 5
18. AB Miller B Hoogstraten M Staquet A. Winkler 1981 Reporting results of cancer treatment Cancer 47 207 14
19. A Trotti R Byhardt J Stetz C Gwede B Corn K Fu 2000 Common toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy Int J Radiat Oncol Biol Phys 47 13 47
20. S. Okada 1998 Chemotherapy in hepatocellular carcinoma Hepatogastroenterology 45 Suppl 3 1259 63
21. M Di Maio E De Maio F Perrone S Pignata B. Daniele 2002 Hepatocellular carcinoma: systemic treatments J Clin Gastroenterol 35 5 Suppl 2 109 14
22. B Sangro R Rios I Bilbao O Beloqui JI Herrero J Quiroga 2002 Efficacy and toxicity of intra-arterial cisplatin and etoposide for advanced hepatocellular carcinoma Oncology 62 293 8
23. J Lee JO Park WS Kim SH Park MS Choi JH Lee 2004 Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma Cancer Chemother Pharmacol 54 385 90
24. JY Pierga V Dieras P Beuzeboc T Dorval T Palangie M Jouve SM Scholl E Garcia-Giralt P. Pouillart 1997 Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma Gynecol Oncol 66 246 9
25. M Ikeda T Okusaka H Ueno Y Takezako C. Morizane 2005 A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma Cancer 103 756 62
26. TS Yang CH Wang RK Hsieh JS Chen MC. Fung 2002 Gemcitabine and doxorubicin for the tratment of patients with advanced hepatocellular carcinoma: a phase II trial Ann Oncol 13 1771 8
27. J Llovet S Ricci V Mazzaferro P Hilgard J Raoul S Zeuzem for the Sharp Investigators Study Group 2007 Randomized phase III trial of sorafenib versus placebo in patients with advanced hepatocellular carcinoma (HCC) (Abstr.) Proc Am Soc Clin Oncol 25 962s
28. FA Shepherd WK Evans ME Blackstein S Fine J Heathcote B Langer 1987 Hepatic arterial infusion of mitoxantrone in the treatment of primary hepatocellular carcinoma J Clin Oncol 5 635 40
29. V Dhir VS Swaroop KM Mohandas KA Dinshaw DC Desai A Nagral 1992 Combination chemotherapy and radiation for palliation of hepatocellular carcinoma Am J Clin Oncol 15 304 7